AASS | Aminoadipate-semialdehyde synthase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ACADM | Acyl-CoA dehydrogenase, C-4 to C-12 straight chain | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ACADS | Acyl-CoA dehydrogenase, C-2 to C-3 short chain | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ACADSB | Acyl-CoA dehydrogenase, short/branched chain | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ACADVL | Acyl-CoA dehydrogenase, very long chain | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ACOX1 | Acyl-CoA oxidase 1, palmitoyl | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ACOX2 | Acyl-CoA oxidase 2, branched chain | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ADH1A | Alcohol dehydrogenase 1A (class I), alpha polypeptide | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
ADH1B | Alcohol dehydrogenase 1B (class I), beta polypeptide | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
ADH1C | Alcohol dehydrogenase 1C (class I), gamma polypeptide | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
ADH4 | Alcohol dehydrogenase 4 (class II), pi polypeptide | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
ADH7 | Alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide | Enzymes Predicted intracellular proteins
| | | | | Tissue enriched |
ADI1 | Acireductone dioxygenase 1 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
ADO | 2-aminoethanethiol (cysteamine) dioxygenase | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
AKR1B1 | Aldo-keto reductase family 1, member B1 (aldose reductase) | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
AKR1C2 | Aldo-keto reductase family 1, member C2 | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Expressed in all |
AKR1C3 | Aldo-keto reductase family 1, member C3 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
AKR1D1 | Aldo-keto reductase family 1, member D1 | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Tissue enriched |
AKR1E2 | Aldo-keto reductase family 1, member E2 | Enzymes Predicted intracellular proteins
| | | | | Tissue enriched |
AKR7A2 | Aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ALDH18A1 | Aldehyde dehydrogenase 18 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ALDH1A1 | Aldehyde dehydrogenase 1 family, member A1 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ALDH1A3 | Aldehyde dehydrogenase 1 family, member A3 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
ALDH1B1 | Aldehyde dehydrogenase 1 family, member B1 | Enzymes Mitochondrial proteins Predicted intracellular proteins
| | | | | Expressed in all |
ALDH1L1 | Aldehyde dehydrogenase 1 family, member L1 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ALDH1L2 | Aldehyde dehydrogenase 1 family, member L2 | Enzymes Predicted intracellular proteins
| | | | | Mixed |
ALDH3A1 | Aldehyde dehydrogenase 3 family, member A1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ALDH4A1 | Aldehyde dehydrogenase 4 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ALDH5A1 | Aldehyde dehydrogenase 5 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ALDH6A1 | Aldehyde dehydrogenase 6 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
ALDH7A1 | Aldehyde dehydrogenase 7 family, member A1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Mixed |
ALKBH2 | AlkB, alkylation repair homolog 2 (E. coli) | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
ALOX12 | Arachidonate 12-lipoxygenase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
AOC3 | Amine oxidase, copper containing 3 | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
AOX1 | Aldehyde oxidase 1 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ASPH | Aspartate beta-hydroxylase | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
BBOX1 | Butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enriched |
BCKDHA | Branched chain keto acid dehydrogenase E1, alpha polypeptide | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
BDH1 | 3-hydroxybutyrate dehydrogenase, type 1 | Candidate cardiovascular disease genes Enzymes Mitochondrial proteins Predicted intracellular proteins
| | | | | Expressed in all |
BDH2 | 3-hydroxybutyrate dehydrogenase, type 2 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
BLVRB | Biliverdin reductase B (flavin reductase (NADPH)) | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
CAT | Catalase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CBR1 | Carbonyl reductase 1 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CBR3 | Carbonyl reductase 3 | Enzymes Predicted intracellular proteins
| | | | | Mixed |
CDO1 | Cysteine dioxygenase type 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
CHDH | Choline dehydrogenase | Enzymes Mitochondrial proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CP | Ceruloplasmin (ferroxidase) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
CPOX | Coproporphyrinogen oxidase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
CRYL1 | Crystallin, lambda 1 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CRYZ | Crystallin, zeta (quinone reductase) | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |